Clinical Trial Results: Positive outcomes for Vanda Pharmaceuticals' clinical trials typically lead to stock price increases, while negative results or trial failures can cause a sharp decline.

Regulatory Decisions: FDA approvals or rejections of Vanda's drug candidates significantly impact the stock price. Approval usually triggers a price surge, and rejection leads to a drop.

Financial Performance: Vanda's revenue, profitability, and earnings reports influence investor sentiment. Strong financial performance generally boosts the stock price, while weak results can depress it.

Market Conditions: Overall market trends and economic conditions can affect Vanda's stock price. A bullish market often lifts stock prices, while a bearish market can lead to declines.

Competition: The competitive landscape in the pharmaceutical industry influences Vanda's market share and profitability. The emergence of new competitors or competing treatments can negatively affect the stock price.

Patent Protection: The strength and duration of Vanda's patent protection for its drugs are crucial. Loss of patent exclusivity can lead to generic competition and lower prices, impacting the stock.

Company News: Major announcements, such as partnerships, acquisitions, or management changes, can affect investor confidence and the stock price.

Analyst Ratings: Ratings and price targets from financial analysts can influence investor decisions. Positive ratings may encourage buying, while negative ratings can trigger selling.

Drug Sales: The performance of Vanda's currently marketed drugs greatly affects its revenue stream. Increased sales usually lead to a positive impact on the stock price, and vice versa.

Investor Sentiment: Overall investor attitude and confidence towards Vanda Pharmaceuticals can significantly impact the stock price.